FibroBiologics, Inc.·4

Dec 30, 4:20 PM ET

Khoja Hamid 4

4 · FibroBiologics, Inc. · Filed Dec 30, 2024

Insider Transaction Report

Form 4
Period: 2024-12-27
Khoja Hamid
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-12-27+176,200176,200 total
    Exercise: $2.36Exp: 2034-12-26Common Stock (176,200 underlying)
Footnotes (1)
  • [F1]On December 27, 2024, the reporting person was granted an option to purchase 176,200 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods.

Documents

1 file
  • 4
    ownership.xmlPrimary